Skip to main content
EPM Company Data

HAWK Biosystems

Company Name
HAWK Biosystems
Joining Date
27/03/2025
Sector
Biotechnology
Scroll to left
Scroll to right
Address
Astondo Bidea 612, mod 02 - Derio - 48160
Founders
Peter J. Parker - Antonio Parente - Antonio Ferrer
CIF
B95827903
Creation Date
22/01/2016
Auditor
Gabino Mesa Auditores, S.L.P.
Presenting Partner
-

View the financial information published by the company in the EpM members area.

Profile

HAWK Biosystems has developed and patented a technology that helps improve the understanding of how treatments, primarily for cancer, work. Its platform enables a more detailed analysis of patient biopsies and how cells respond to specific drugs. This helps support the development of more effective and personalized therapies, while also accelerating the development of new medicines.

At HAWK Biosystems, we are committed to innovation in precision medicine, and being part of BME’s Pre-Market Environment represents a strategic step in our growth. This program provides us with access to a network of investors and capital market experts, facilitating new opportunities to consolidate our development and accelerate the expansion of our QF-Pro® technology. We believe that the stock market route is a key alternative to strengthen our impact on the biomedical industry and to continue advancing our mission to transform cancer treatment.

Fernando Aguirre CEO